ALMS
Price
$4.91
Change
+$0.07 (+1.45%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
499.44M
79 days until earnings call
ATXS
Price
$6.42
Change
-$0.37 (-5.45%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
383.19M
79 days until earnings call
Interact to see
Advertisement

ALMS vs ATXS

Header iconALMS vs ATXS Comparison
Open Charts ALMS vs ATXSBanner chart's image
Alumis
Price$4.91
Change+$0.07 (+1.45%)
Volume$6.99K
Capitalization499.44M
Astria Therapeutics
Price$6.42
Change-$0.37 (-5.45%)
Volume$2.54K
Capitalization383.19M
ALMS vs ATXS Comparison Chart in %
Loading...
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALMS vs. ATXS commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a StrongBuy and ATXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (ALMS: $4.84 vs. ATXS: $6.79)
Brand notoriety: ALMS and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 90% vs. ATXS: 165%
Market capitalization -- ALMS: $499.44M vs. ATXS: $383.19M
ALMS [@Biotechnology] is valued at $499.44M. ATXS’s [@Biotechnology] market capitalization is $383.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 1 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • ALMS’s FA Score: 1 green, 4 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, ALMS is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 5 TA indicator(s) are bullish while ATXS’s TA Score has 5 bullish TA indicator(s).

  • ALMS’s TA Score: 5 bullish, 4 bearish.
  • ATXS’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than ALMS.

Price Growth

ALMS (@Biotechnology) experienced а +1.89% price change this week, while ATXS (@Biotechnology) price change was -0.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

ALMS is expected to report earnings on Nov 12, 2025.

ATXS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALMS($499M) has a higher market cap than ATXS($383M). ATXS YTD gains are higher at: -24.049 vs. ALMS (-38.422). ATXS has higher annual earnings (EBITDA): -131.42M vs. ALMS (-435.74M). ALMS has more cash in the bank: 486M vs. ATXS (259M). ATXS has less debt than ALMS: ATXS (4.77M) vs ALMS (38.8M). ALMS has higher revenues than ATXS: ALMS (20.1M) vs ATXS (0).
ALMSATXSALMS / ATXS
Capitalization499M383M130%
EBITDA-435.74M-131.42M332%
Gain YTD-38.422-24.049160%
P/E Ratio0.15N/A-
Revenue20.1M0-
Total Cash486M259M188%
Total Debt38.8M4.77M814%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALMSATXS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCECX35.451.17
+3.41%
Fidelity Advisor Consumer Discret C
IMCGX11.260.22
+1.99%
Transamerica Mid Cap Growth I
MEQAX11.260.13
+1.17%
American Century International Val A
FRIQX12.210.07
+0.58%
Fidelity Advisor Real Estate Income M
ABRWX18.31N/A
N/A
DSS AmericaFirstMonthlyRisk-OnRisk-Off I

ALMS and

Correlation & Price change

A.I.dvisor tells us that ALMS and ADAP have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
+5.22%
ADAP - ALMS
29%
Poorly correlated
-2.74%
ATXS - ALMS
26%
Poorly correlated
+6.93%
ELEV - ALMS
24%
Poorly correlated
N/A
HALO - ALMS
24%
Poorly correlated
+0.29%
OABI - ALMS
23%
Poorly correlated
+2.78%
More

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+6.93%
CRNX - ATXS
52%
Loosely correlated
+5.17%
XENE - ATXS
51%
Loosely correlated
+1.73%
DNLI - ATXS
51%
Loosely correlated
+1.71%
COGT - ATXS
49%
Loosely correlated
+2.97%
NRIX - ATXS
49%
Loosely correlated
+5.08%
More